Healwell AI Inc. (HWAIF)
| Market Cap | 144.46M -44.3% |
| Revenue (ttm) | 90.65M +135.3% |
| Net Income | -20.86M |
| EPS | -0.07 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 160 |
| Open | 0.4034 |
| Previous Close | 0.4633 |
| Day's Range | 0.4034 - 0.4889 |
| 52-Week Range | 0.3934 - 0.9500 |
| Beta | -0.96 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 9, 2026 |
About Healwell AI
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also... [Read more]
Financial Performance
In 2025, Healwell AI's revenue was 103.80 million, an increase of 426.62% compared to the previous year's 19.71 million. Losses were -47.11 million, 79.2% more than in 2024.
Financial numbers in CAD Financial StatementsNews
Healwell AI Earnings release: Q3 2026
Healwell AI released its Q3 2026 earnings on November 10, 2026, summarizing the period's financial results.
Healwell AI Report: Q3 2026
Healwell AI published a report on November 10, 2026 containing material business information for investors and shareholders.
Healwell AI MD&A: Q3 2026
Healwell AI filed a regulatory document on November 10, 2026 disclosing important business information.
HEALWELL More than Doubles YoY Adjusted EBITDA in Q3-2026 and Improves YTD Operating Cashflow by $26 Million
HEALWELL achieved revenue from continuing operations of $32.6 million in Q3-2026, an increase of 7% compared to revenue of $30.4 million in Q3-2025. HEALWELL reported positive Adjusted EBITDA1 of $1.6...
Healwell AI price target lowered to C$2 from C$2.25 at Stifel
Stifel analyst Justin Keywood lowered the firm’s price target on Healwell AI (HWAIF) to C$2 from C$2.25 and keeps a Buy rating on the shares.
HEALWELL AI Announces Conference Call for Third Quarter 2026 Financial Results on November 10, 2026
HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 10, 2026, at 8:30 am EST (6:30 am PCT). Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - HEALWELL AI Inc. (TS...
HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter
Toronto, Ontario and Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence ...
HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.
HEALWELL has been named to TIME's World's Top HealthTech Companies of 2026, a ranking of 500 companies. HEALWELL and its collaborators are presenting 12 scientific abstracts and presentations at 8 int...
HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)
Peer-reviewed research published in the Journal of Medical Internet Research (JMIR) reports that VeroSource's MyHealth patient app was associated with statistically significant, self-reported improvem...
HEALWELL AI to Present at the Cantech Investment Conference on October 8th in Toronto
Toronto, Ontario--(Newsfile Corp. - September 28, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventativ...
HEALWELL Expands SMART Summary AI Deployment Across New Brunswick
HEALWELL AI, through its subsidiary Intrahealth Canada Limited ("Intrahealth"), has deployed SMART Summary across New Brunswick, delivering AI-powered clinical summarization directly within Profile, t...
HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research
New research accepted for presentation at AMIA 2026 demonstrates the performance of HEALWELL's DARWEN™ AI-powered SMARTSuite, including clinical summarization results that outperformed published bench...
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching ...
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to ...
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
HEALWELL, through its subsidiary Orion Health, has entered into an agreement with the statewide designated Health Information Exchange of Iowa, Converge Health Iowa, to deploy DARWEN™-powered SMART Se...
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN™ AI as a globally recognized heal...
Healwell AI price target lowered to C$1.50 from C$2 at Alliance Global
Alliance Global analyst Brian Kinstlinger lowered the firm’s price target on Healwell AI (HWAIF) to C$1.50 from C$2 and keeps a Buy rating on the shares following the Q2 report.
Healwell AI Earnings Call Transcript: Q2 2026
Q2 2026 revenue was CAD 33 million, flat year-over-year, with positive adjusted EBITDA and strong operating cash flow. The business is transitioning to recurring enterprise sales, with robust AI adoption and a healthy pipeline, targeting a 10% adjusted EBITDA margin by year-end.
Healwell AI Earnings release: Q2 2026
Healwell AI released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
HEALWELL achieved revenue from continuing operations of $33.0 million in Q2-2026 compared to revenue of $33.2 million in Q2-2025. Revenue remained consistent with the prior year, as one-time professio...
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
HEALWELL AI to hold a conference call and simultaneous webcast on Friday, August 7, 2026, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - HEALWELL AI Inc. (TSX: AIDX)...
Healwell AI price target raised to C$2 from C$1.50 at Scotiabank
Scotiabank raised the firm’s price target on Healwell AI (HWAIF) to C$2 from C$1.50 and keeps an Outperform rating on the shares.
HEALWELL AI Announces Voting Results of 2026 AGSM
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative ca...
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
HEALWELL successfully completed a pilot evaluating its DARWEN™ AI powered SMART Summary™ and SMART Search™ solutions in multiple provinces across Canada. The pilot demonstrated how clinically validate...
Healwell AI price target lowered to C$2 from C$2.25 at Alliance Global
Alliance Global analyst Brian Kinstlinger lowered the firm’s price target on Healwell AI (HWAIF) to C$2 from C$2.25 and keeps a Buy rating on the shares. The firm updated the…